Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Growth of Two Human Tumour Cell Lines in Mice treated with Antilymphocyte Serum

Abstract

TISSUE culture lines of human tumours can be transplanted into animal hosts conditioned with immunological depressants such as cortisone or irradiation1. Several reports2,3 describe the immunosuppressive action of antilymphocyte serum; mice treated with antilymphocyte serum have a reduced capacity to reject skin homografts. Antilymphocyte serum seems to be the most effective immunosuppressant yet discovered, and because of its specificity and low toxicity it may provide an improved alternative to methods of host conditioning at present used in tumour transplantation. We have been able to grow two human tumour cell lines in mice treated with antilymphocyte serum.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Toolan, H., Cancer Res., 14, 660 (1954).

    CAS  PubMed  Google Scholar 

  2. Levey, R. H., Medawar, P. B., Proc. US Nat. Acad. Sci., 56, 1130 (1966).

    Article  ADS  CAS  Google Scholar 

  3. Gray, J. G., Monaco, A. P., and Russell, P. S., Surg. Forum, 15, 142 (1964).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

PHILLIPS, B., GAZET, JC. Growth of Two Human Tumour Cell Lines in Mice treated with Antilymphocyte Serum. Nature 215, 548–549 (1967). https://doi.org/10.1038/215548a0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/215548a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing